Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call Transcript

SA Transcripts 161.45K Followers Follow Inspire Medical Systems, Inc. ( INSP ) Q2 2026 Earnings Call August 3, 2026 5:00 PM EDT Company Participants Ezgi Yagci - Vice President of Investor Relations Timothy Herbert - Founder, Chairman, CEO & President Matthew Osberg - Executive VP & CFO Conference Call Participants Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Adam Maeder - Piper Sandler & Co., Research Division Robert Marcus - JPMorgan Chase & Co, Research Division Anthony Petrone - Mizuho Securities USA LLC, Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Travis Steed - BofA Securities, Research Division Richard Newitter - Truist Securities, Inc., Research Division Michael Polark - Wolfe Research, LLC David Rescott - Robert W. Baird & Co. Incorporated, Research Division Michael Sarcone - Jefferies LLC, Research Division Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Daniel Markowitz - Evercore ISI Institutional Equities, Research Division Keith Hinton Michael Kratky - Leerink Partners LLC, Research Division Presentation Operator Good afternoon. My name is Dilem, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Inspire Medical Systems Second Quarter 2026 Conference Call. [Operator Instructions] I'll now hand the call over to your first speaker, Ezgi Yagci, the Vice President of Investor Relations at Inspire. You may begin the conference. Ezgi Yagci Vice President of Investor Relations Thank you, Dilem, and thank you all for participating in today's call. Joining me are Tim Herbert, Chairman and Chief Executive Officer; and Matt Osberg, Chief Financial Officer. Earlier today, we released financial results for the 3 months ended June 30, 2026. A copy of the press release is available on our website. On this call, management will make forward-looking statements within the meaning of the federal securities laws. All forward-looking statements, including, without limitation, those relating to our operations, financial results and financial condition, investments in our business, full year 2026 financial and operational outlook and changes in market access and